Literature DB >> 28209815

Whole-Genome Sequence of a Colombian Acinetobacter baumannii Strain, a Coproducer of OXA-72 and OXA-255-Like Carbapenemases.

Sandra Yamile Saavedra1, Diego Prada-Cardozo2,3, Verónica Rincón4,3, Hermes Pérez-Cardona2, Andrea Melissa Hidalgo1, María Nilse González1, María T Reguero2,3, Emilia M Valenzuela de Silva3, José R Mantilla3, Laurent Falquet5, Emiliano Barreto-Hernández2,3, Carolina Duarte1.   

Abstract

Colombian Acinetobacter baumannii strain ST920 was isolated from the sputum of a 68-year-old male patient. This isolate possessed blaOXA-72 and blaOXA-255-like genes. The assembled genome contained 4,104,098 pb and 38.79% G+C content. This is the first case reported of the coproduction (blaOXA-72 and blaOXA-255-like) of carbapenem-hydrolyzing class D β-lactamases (CHDLs) in Acinetobacter baumannii.
Copyright © 2017 Saavedra et al.

Entities:  

Year:  2017        PMID: 28209815      PMCID: PMC5313607          DOI: 10.1128/genomeA.01558-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The resistance to carbapenemases in Acinetobacter baumannii has primarily been associated with the production of carbapenem-hydrolyzing class D β-lactamases (CHDLs). Six different groups of CHDLs have been described for Acinetobacter baumannii, where the OXA-51-like group is intrinsically chromosomal, while the other groups are acquired: OXA-23-like, OXA-40/24-like, OXA-58-like, OXA-143-like, and OXA-235-like (1, 2). In Latin American, the high prevalence of multidrug resistant A. baumannii strains is one of the principal causes of health care-associated infections (HAI) (3–7). As part of the HAI surveillance program, the Microbiology Group of the National Institute of Health of Colombia isolated the GMR_RB_1399 strain in May 2014 from the sputum of a 68-year-old male patient. This strain was identified as Acinetobacter baumannii using the automatic system Phoenix (Becton Dinckinson) and its antimicrobial susceptibility testing (E test, bioMérieux) showed resistance to imipenem, meropenem, doripenem, and piperacillin-tazobactam and susceptibility to ceftazidime, cefepime, ampicilin-sulbactam, ciprofloxacin, amikacin, gentamicin, and colistin according to the Clinical and Laboratory Standards Institute (8). Therefore, this strain was classified as multidrug resistant (MDR) according to the standardized international terminology (9). The genomic DNA was extracted using the QIAamp DNA minikit (QIAGEN). The DNA quantification was performed using Quant-iT PicoGreen dsDNAPicogreen (Invitrogen), using Victor three fluorometry (PerkinElmer). The library was constructed with the TruSeq DNA PCR-free sample preparation kit (Illumina). This library was sequenced using the Hiseq2000 system (Illumina). A total of 4,395,897 paired-end reads were obtained, with an average length of 101 pb. De novo assembly was carried out using SPAdes version 3.8 (10), resulting in 24 contigs, 4,104,098 pb, 180× coverage and 38.79% G+C content. The GMR_RB_1399 strain was identified as a new sequence type (ST) by multilocus sequence typing (MLST) analysis using the Pasteur scheme (CGE server). The strain was registered in the pubMLST database (http://pubmlst.org/abaumannii/submission.shtml) as an ST920. The annotation process was performed using Prokka software (11), which was enriched with the following databases: Resfam (12), CARD (13), Gibsy (14), and VFDB (15). Prokka annotated 3,785 coding sequences (CDSs), three rRNAs, 65 tRNAs, one transfer-messenger RNA (tmRNA), and 3,854 genes. The genome annotation showed the following carbapenemases: blaOXA-72 (OXA-40/24-like), blaOXA-255-like (OXA-143-like), and blaOXA-106-like (OXA-51-like). blaOXA-106-like presented a single amino acid change (Thr97Ser). In different studies, OXA-72-producing Acinetobacter baumannii isolates showed resistance to all β-lactams, included carbapenemes (16–22). It was first reported in Thailand (23) but has now spread to several continents (16–27), including South America (22, 23, 26, 27) and Colombia, where there is already a report of its presence in an Acinetobacter baumannii strain (22). This is the first case reported in Colombia of the presence of OXA-255-like (OXA-143-like) and the first report of its presence in Acinetobacter baumannii ever. blaOXA-255-like had two amino acid changes (Ser158Asn and Ala183Val), differs from OXA-143 in 18 amino acids and was found previously in Acinetobacter pittii with a carbapenem-resistant profile (27–29). Additionally, this is also the first case reported of the coproduction (blaOXA-72 and blaOXA-255-like) of CHDLs in Acinetobacter baumannii.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession no. MPPK00000000.
  27 in total

1.  GIPSy: Genomic island prediction software.

Authors:  Siomar C Soares; Hakan Geyik; Rommel T J Ramos; Pablo H C G de Sá; Eudes G V Barbosa; Jan Baumbach; Henrique C P Figueiredo; Anderson Miyoshi; Andreas Tauch; Artur Silva; Vasco Azevedo
Journal:  J Biotechnol       Date:  2015-09-12       Impact factor: 3.307

2.  Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.

Authors:  Esther Zander; Rémy A Bonnin; Harald Seifert; Paul G Higgins
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico.

Authors:  Paola Bocanegra-Ibarias; Cynthia Peña-López; Adrian Camacho-Ortiz; Jorge Llaca-Díaz; Jesús Silva-Sánchez; Humberto Barrios; Ulises Garza-Ramos; Adrian Marcelo Rodríguez-Flores; Elvira Garza-González
Journal:  Int J Antimicrob Agents       Date:  2014-12-05       Impact factor: 5.283

4.  Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology.

Authors:  Molly K Gibson; Kevin J Forsberg; Gautam Dantas
Journal:  ISME J       Date:  2014-07-08       Impact factor: 10.302

5.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

Review 6.  Gram-negative infections in pediatric and neonatal intensive care units of Latin America.

Authors:  Eitan N Berezin; Fortino Solórzano
Journal:  J Infect Dev Ctries       Date:  2014-08-13       Impact factor: 0.968

Review 7.  OXA-type carbapenemases in Acinetobacter baumannii in South America.

Authors:  Andrés Opazo; Mariana Domínguez; Helia Bello; Sebastian G B Amyes; Gerardo González-Rocha
Journal:  J Infect Dev Ctries       Date:  2012-04-13       Impact factor: 0.968

8.  Whole-Genome Sequence of a European Clone II and OXA-72-Producing Acinetobacter baumannii Strain from Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Delphine Girlich; Dilek Imanci; Sandrine Bernabeu; Nicolas Fortineau; Thierry Naas
Journal:  Genome Announc       Date:  2015-12-10

Review 9.  Acquired Class D β-Lactamases.

Authors:  Nuno T Antunes; Jed F Fisher
Journal:  Antibiotics (Basel)       Date:  2014-08-21

10.  First report of OXA-72 producing Acinetobacter baumannii in Romania.

Authors:  M Georgescu; I Gheorghe; A Dudu; I Czobor; M Costache; V-C Cristea; V Lazăr; M C Chifiriuc
Journal:  New Microbes New Infect       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.